CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
- DOI
- 10.1136/jnnp.2009.199398
- Published
- 2011 Feb
- Container
- Journal of neurology, neurosurgery, and psychiatry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jnnp.2009.199398,
title = {CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.},
author = {Mulugeta E and Londos E and Ballard C and Alves G and Zetterberg H and Blennow K and Skogseth R and Minthon L and Aarsland D},
year = {2011},
journal = {Journal of neurology, neurosurgery, and psychiatry},
doi = {10.1136/jnnp.2009.199398},
url = {https://doi.org/10.1136/jnnp.2009.199398}
}RIS
TY - JOUR TI - CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies. AU - Mulugeta E AU - Londos E AU - Ballard C AU - Alves G AU - Zetterberg H AU - Blennow K AU - Skogseth R AU - Minthon L AU - Aarsland D PY - 2011 JO - Journal of neurology, neurosurgery, and psychiatry DO - 10.1136/jnnp.2009.199398 UR - https://doi.org/10.1136/jnnp.2009.199398 ER -
APA
E, M., E, L., C, B., G, A., H, Z., K, B., R, S., L, M., & D, A. (2011). CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp.2009.199398
Source records
- pubmed · retrieved 2026-09-25T22:16:25.825Z